BE881297A - Procede pour la fabrication de chlorhydrate de 6,7-dimethoxy-4-amino-2- 4-(2-furoyl)-1-piperazinyl quinazoline ayant un effet antihypertensif - Google Patents

Procede pour la fabrication de chlorhydrate de 6,7-dimethoxy-4-amino-2- 4-(2-furoyl)-1-piperazinyl quinazoline ayant un effet antihypertensif

Info

Publication number
BE881297A
BE881297A BE0/199070A BE199070A BE881297A BE 881297 A BE881297 A BE 881297A BE 0/199070 A BE0/199070 A BE 0/199070A BE 199070 A BE199070 A BE 199070A BE 881297 A BE881297 A BE 881297A
Authority
BE
Belgium
Prior art keywords
furoyl
dimethoxy
amino
manufacture
antihypertensive effect
Prior art date
Application number
BE0/199070A
Other languages
English (en)
French (fr)
Inventor
E J Jonkanen
A K Pippuri
P J Kairisalo
H Thaler
M K Koivisto
S A Tuomi
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of BE881297A publication Critical patent/BE881297A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
BE0/199070A 1979-01-31 1980-01-23 Procede pour la fabrication de chlorhydrate de 6,7-dimethoxy-4-amino-2- 4-(2-furoyl)-1-piperazinyl quinazoline ayant un effet antihypertensif BE881297A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan

Publications (1)

Publication Number Publication Date
BE881297A true BE881297A (fr) 1980-05-16

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/199070A BE881297A (fr) 1979-01-31 1980-01-23 Procede pour la fabrication de chlorhydrate de 6,7-dimethoxy-4-amino-2- 4-(2-furoyl)-1-piperazinyl quinazoline ayant un effet antihypertensif

Country Status (21)

Country Link
US (1) US4271300A (US20100012521A1-20100121-C00001.png)
JP (1) JPS55104280A (US20100012521A1-20100121-C00001.png)
AT (1) AT374475B (US20100012521A1-20100121-C00001.png)
BE (1) BE881297A (US20100012521A1-20100121-C00001.png)
CA (1) CA1128945A (US20100012521A1-20100121-C00001.png)
CH (1) CH644605A5 (US20100012521A1-20100121-C00001.png)
CS (1) CS214692B2 (US20100012521A1-20100121-C00001.png)
DD (1) DD148952A1 (US20100012521A1-20100121-C00001.png)
DE (1) DE3002553A1 (US20100012521A1-20100121-C00001.png)
DK (1) DK158352C (US20100012521A1-20100121-C00001.png)
FI (1) FI67699C (US20100012521A1-20100121-C00001.png)
FR (1) FR2447920A1 (US20100012521A1-20100121-C00001.png)
GB (1) GB2041932B (US20100012521A1-20100121-C00001.png)
HU (1) HU181016B (US20100012521A1-20100121-C00001.png)
NL (1) NL190701C (US20100012521A1-20100121-C00001.png)
NO (1) NO152298C (US20100012521A1-20100121-C00001.png)
PL (1) PL126994B1 (US20100012521A1-20100121-C00001.png)
SE (1) SE430692B (US20100012521A1-20100121-C00001.png)
SU (1) SU900812A3 (US20100012521A1-20100121-C00001.png)
YU (1) YU41498B (US20100012521A1-20100121-C00001.png)
ZA (1) ZA80501B (US20100012521A1-20100121-C00001.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390014A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv Process for the preparation of carbocyclic fused pyrimidine derivatives
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan

Also Published As

Publication number Publication date
YU5880A (en) 1983-02-28
NL8000289A (nl) 1980-08-04
NO152298B (no) 1985-05-28
FI67699B (fi) 1985-01-31
FR2447920B1 (US20100012521A1-20100121-C00001.png) 1982-12-03
GB2041932A (en) 1980-09-17
YU41498B (en) 1987-08-31
SE8000777L (sv) 1980-08-01
SE430692B (sv) 1983-12-05
PL126994B1 (en) 1983-09-30
ZA80501B (en) 1981-02-25
FI67699C (fi) 1985-05-10
JPS6310955B2 (US20100012521A1-20100121-C00001.png) 1988-03-10
AT374475B (de) 1984-04-25
NO152298C (no) 1985-09-04
CH644605A5 (de) 1984-08-15
NL190701B (nl) 1994-02-01
CS214692B2 (en) 1982-05-28
NL190701C (nl) 1994-07-01
FR2447920A1 (fr) 1980-08-29
DK158352C (da) 1990-10-08
GB2041932B (en) 1982-10-27
NO794279L (no) 1980-08-01
US4271300A (en) 1981-06-02
HU181016B (en) 1983-05-30
DD148952A1 (de) 1981-06-17
DE3002553A1 (de) 1980-08-07
DE3002553C2 (US20100012521A1-20100121-C00001.png) 1988-10-27
DK42680A (da) 1980-08-01
CA1128945A (en) 1982-08-03
SU900812A3 (ru) 1982-01-23
JPS55104280A (en) 1980-08-09
FI790320A (fi) 1980-08-01
ATA19580A (de) 1983-09-15
DK158352B (da) 1990-05-07
PL221684A1 (US20100012521A1-20100121-C00001.png) 1980-10-20

Similar Documents

Publication Publication Date Title
RO81173A (ro) Procedeu pentru prepararea unor derivati de delta2-1,2,4-triazolin-5-ona
MA21786A1 (fr) Procede de preparation de pteridin - 4 (3h) - ones .
ES510888A0 (es) "procedimiento para la produccion de derivados de 1-aril-2-azolileteno".
YU41294B (en) Process for obtaining the crystalline alpha-from of 2-(4(2-furoy)-piperazione-1-yl)-4-amino-6,7-dimethoxy quinazoline hydroclorides
AR230437A1 (es) Procedimiento para la fabricacion de derivados de 2-(dialquamino,pirrolidinil o piperidinil)-alquil-tio-quinolina
ES513916A0 (es) "procedimiento para la produccion de dimetileter".
BE881297A (fr) Procede pour la fabrication de chlorhydrate de 6,7-dimethoxy-4-amino-2- 4-(2-furoyl)-1-piperazinyl quinazoline ayant un effet antihypertensif
IT8023315A0 (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione.
FR2669636B1 (fr) Procede de fabrication de furane 2,5-dicarboxaldehyde.
IT1147923B (it) Procedimento per la produzione di ditiazolil-2(2.2')-disolfuri
MA21849A1 (fr) Procede de fabrication d'alkyl - ethoxy - carboxylates .
IT1145435B (it) Procedimento per la produzione di 2,3-dimetilbutene-2
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
BE882655A (fr) Procede de fabrication de dimethylacetal d'acetaldehyde
RO90233A (ro) Procedeu pentru prepararea unor derivati de 1,2,4(tia)-diazolin-3-ona
IT1145279B (it) Procedimento per la produzione di 3-(4)-formiltriciclo(5,2,1,0,2,6)-decene-8
RO79906A (ro) Procedeu pentru prepararea unor derivati de 1,1'-difenil 2-ilalchilamina
ZA777223B (en) Method for the production of 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)quinazoline having an antihypertensive effect
IT1239163B (it) Procedimento per la produzione di feltri per cappello.
FR2521556B1 (fr) Procede de preparation de 3, 3'-diamino-diphenylsulfones
FR2663320B1 (fr) Procede de preparation de dialcoxybutenes.
AR227793A1 (es) Procedimiento para la produccion de derivados de 1,4-dioxido de 2-alpha-de derivados de 1,4-dioxido de 2-(alpha-hidrazino-alpha-hidroximetil)-quinoxalina
FR2562074B1 (fr) Procede de preparation de derives de 2,2-bishalomethylpename
RO88729A2 (ro) Procedeu de obtinere a 0,0-dialchil-0-(2,3-dihidro-2,2-dimetil-5-r-7-benzofuranil)-fosforotioatilor

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ORION-YHTYMA OY

Effective date: 19960131